Acadia Healthcare's biggest risks in the FY2024 10-K
- Behavioral healthcare provider faces heavy federal and state regulatory burdens, government reimbursement dependence, and litigation risks.
The risks most specific to Acadia Healthcare
- Legal Proceedings and Regulatory Risks
We are and in the future could become the subject of governmental investigations, regulatory actions, whistleblower lawsuits and other legal proceedings
The Company and certain individual facilities receive subpoenas, civil investigative demands, and inquiries from federal and state agencies and whistleblower lawsuits.
- Legal Proceedings and Regulatory Risks
We carry a large self-insured retention and may be responsible for significant amounts not covered by insurance. In addition, our insurance may be inadequate, premiums may increase and, if there is a significant deterioration in our claims experience, insurance may not be available on acceptable terms
Medical malpractice lawsuits and other legal actions, such as the Desert Hills Litigation, involve large claims and significant defense costs.
- Financial Risks
A significant portion of our revenue is derived from government healthcare programs. For the year ended December 31, 2024, we derived approximately 71% of our revenue from the Medicare and Medicaid programs
For the year ended December 31, 2024, approximately 71% of revenue was derived from the Medicare and Medicaid programs.
- Financial Risks
Our debt could adversely affect our financial health and prevent us from fulfilling our obligations under our financing arrangements
Total debt at December 31, 2024 was approximately $2.0 billion, including $1.0 billion under the Credit Facility, $450.0 million of 5.500% Senior Notes, and $475.0 million of 5.000% Senior Notes.
- Financial Risks
Despite our current debt level, we may incur significant additional amounts of debt, which could further exacerbate the risks associated with our debt
In January 2024, the Second Amendment provided for the incurrence of $350.0 million of Incremental Term Loans.
- Operational Risks
An incident involving one or more of our patients or the failure by one or more of our facilities to provide appropriate care could result in increased regulatory burdens, governmental investigations, litigation, negative publicity and adversely affect the trading price of our common stock
Patients treated suffer from severe mental health and chemical dependency disorders, leading to patient incidents including deaths, sexual abuse, assaults, and elopements.
All 65 risk factors
Headings as the filing states them, in filing order.
Legal Proceedings and Regulatory Risks
- 01We are and in the future could become the subject of governmental investigations, regulatory actions, whistleblower lawsuits and other legal proceedings
- 02We are and in the future may become involved in legal proceedings based on negligence or breach of a contractual or statutory duty from service users or their family members or from employees or former employees
- 03We carry a large self-insured retention and may be responsible for significant amounts not covered by insurance. In addition, our insurance may be inadequate, premiums may increase and, if there is a significant deterioration in our claims experience, insurance may not be available on acceptable terms
- 04We handle sensitive personal data which are protected by numerous U.S. laws in the ordinary course of business and any failure to maintain the confidentiality of such data could result in legal liability and reputational harm
- 05If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations
- 06Surprises Act and the Health Care PRICE Transparency Act may impact our ability to obtain or maintain favorable contract terms, and may impact our competitive position and our relationships with patients and insurers
- 07We may be required to spend substantial amounts to comply with statutes and regulations relating to privacy and security of PHI
- 08public attention is drawn to the issues of the privacy and security of medical information, states may revise or expand their laws concerning the use and disclosure of health information, or may adopt new laws addressing these subjects
- 09We could face risks associated with, or arising out of changing laws and regulations, including those involving environmental, health and safety laws and regulations
- 10regulate workplace safety
- 11State efforts to regulate the construction or expansion of healthcare facilities could impair our ability to operate and expand our operations
- 12We are required to treat patients with emergency medical conditions regardless of ability to pay
Financial Risks
- 13Our revenue and results of operations are significantly affected by payments received from the government and third-party payors
- 14A significant portion of our revenue is derived from government healthcare programs. For the year ended December 31, 2024, we derived approximately 71% of our revenue from the Medicare and Medicaid programs
- 15Our debt could adversely affect our financial health and prevent us from fulfilling our obligations under our financing arrangements
- 16limit our ability to pay dividends, redeem stock or make other distributions
- 17Servicing our debt requires a significant amount of cash. Our ability to generate sufficient cash to service our debt depends on many factors beyond our control
- 18We are subject to a number of restrictive covenants, which may restrict our business and financing activities
- 19merge or consolidate with other companies
- 20Despite our current debt level, we may incur significant additional amounts of debt, which could further exacerbate the risks associated with our debt
- 21If we default on our obligations to pay our debt, we may not be able to make payments on our financing arrangements
- 22We may be required to record additional charges to future earnings if our goodwill, intangible assets and property and equipment become impaired
- 23Our operating costs are subject to increases in the wages and salaries of our staff
- 24We are subject to volatility in the global capital and credit markets as well as significant developments in macroeconomic and political conditions that are out of our control
- 25A worsening of the economic and employment conditions in the geographies in which we operate could materially affect our business and future results of operations
- 26Increased inflationary pressure and rising interest rates may adversely impact our business, financial condition and results of operations
- 27The industry trend on value-based purchasing may negatively impact our revenue
- 28The trend by insurance companies and managed care organizations to enter into sole-source contracts may limit our ability to obtain patients
- 29An increase in uninsured or underinsured patients or the deterioration in the collectability of patient accounts receivables could harm our results of operations
- 30Failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) could have a material adverse effect on our business
- 31We do not anticipate paying any cash dividends in the foreseeable future
Operational Risks
- 32An incident involving one or more of our patients or the failure by one or more of our facilities to provide appropriate care could result in increased regulatory burdens, governmental investigations, litigation, negative publicity and adversely affect the trading price of our common stock
- 33Joint ventures may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities
- 34Our ability to grow our business through organic expansion is dependent on capacity and occupancy at our facilities. Should our facilities reach maximum occupancy, we may need to implement other growth strategies either by developing de novo or joint venture facilities or by modifying existing facilities
- 35Our business growth and acquisition strategies expose us to a variety of operational and financial risks
- 36Integrating a newly acquired facility could be expensive and time consuming and could disrupt our ongoing business, negatively affect cash flow and distract management and other key personnel from day-to-day operations
- 37Benefits may not materialize
- 38Assumptions of unknown liabilities
- 39Competing for acquisitions
- 40Antitrust and other legal challenges
- 41We incur significant transaction-related costs in connection with acquisitions and other strategic transactions
- 42We care for a large number of vulnerable individuals with complex needs and any care quality deficiencies could adversely impact our brand, reputation and ability to market our services effectively
- 43The cost of construction materials and labor has significantly increased, and we continue to grow our business through expansion of existing facilities and development of de novo and joint venture facilities
- 44Our business could be disrupted if our information systems fail or if our databases are destroyed or damaged
- 45If we do not continually enhance our facilities with the most recent technological advances, our ability to maintain and expand our markets will be adversely affected
- 46A cybersecurity incident could have a material adverse impact on us, including substantial sanctions, fines, and damages and civil and criminal penalties under federal and state privacy laws, in addition to reputational harm and increased costs
- 47We may fail to deal with clinical waste in accordance with applicable regulations or otherwise be in breach of relevant medical, health and safety or environmental laws and regulations
- 48Although we have facilities in 39 states and Puerto Rico, we have substantial operations in Pennsylvania, California and Tennessee, which makes us especially sensitive to regulatory, economic, environmental and competitive conditions and changes in those states
- 49Our business and operations are subject to risks related to natural disasters and climate change
- 50A pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise impacts our facilities could adversely impact our business
- 51If we fail to cultivate new or maintain established relationships with referral sources, our business, financial condition and results of operations could be adversely affected
- 52We operate in a highly competitive industry, and competition may lead to declines in patient volumes
- 53We may be unable to extend leases at expiration, which could harm our business, financial condition or results of operations
- 54Controls designed to reduce inpatient services may reduce our revenue
- 55We are a holding company with no operations and rely upon our subsidiaries to provide us with the funds necessary to meet our financial obligations. Liabilities of any one or more of our subsidiaries could be imposed upon us or our other subsidiaries
Human Capital Risks
- 56Our facilities face competition for staffing, labor shortages and higher turnover rates that may increase our labor costs and reduce our profitability
- 57Our performance depends on our ability to recruit and retain quality psychiatrists and other physicians, and nurses, counselors and other medical support personnel
- 58Some of our employees are represented by labor unions and any work stoppage could adversely affect our business
- 59We depend on key management personnel, and the departure of one or more of our key executives or a significant portion of our local facility management personnel could harm our business
- 60Provisions of our charter documents or Delaware law could delay or prevent an acquisition of us, even if the acquisition would be beneficial to our stockholders, and could make it more difficult for stockholders to change management
- 61the authority of the board of directors to issue preferred stock with such terms as the board of directors may determine
- 62Fluctuations in our operating results, quarter to quarter earnings and other factors, including factors outside our control, may result in significant decreases in the price of our common stock
- 63Future sales of common stock by our existing stockholders may cause our stock price to fall
- 64If securities or industry analysts do not publish research or reports about our business, if they were to change their recommendations regarding our stock adversely or if our operating results do not meet their expectations, our stock price and trading volume could decline
- 65We incur substantial costs as a result of being a public company
Other Acadia Healthcare 10-Ks
- FY2025 10-K risk factors66 risks4 new3 dropped11 reworded
Acadia Healthcare faces severe leadership instability with CEO, CFO, and COO departures reported in late 2025 and early 2026. Debt levels rose to $2.5 billion, driven by new senior notes and credit facilities. Heavy revenue reliance on Medicare and Medicaid remains at 72%.
Filed Feb 27, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.